back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-05 20:15 Tx date 2024-09-03 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
600,000 | |
| Filed 2023-05-16 16:17 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
400,000 | |
| Filed 2023-03-01 13:28 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,500
+25,000 vol $0.10 each |
25,000 | |
| Filed 2023-03-01 13:23 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$2,500
+25,000 vol $0.10 each |
||
| Filed 2022-12-09 14:31 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$2,500
+25,000 vol $0.10 each |
||
| Filed 2022-12-09 14:31 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$2,500
+25,000 vol $0.10 each |
225,000 | |
| Filed 2022-12-09 14:28 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,500
-25,000 vol $0.10 each |
200,000 | |
| Filed 2022-08-12 18:32 Tx date 2022-07-20 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-150,000 vol |
100,000 | |
| Filed 2022-08-12 18:32 Tx date 2022-07-20 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-150,000 vol |
100,000 | |
| Filed 2022-08-12 16:06 Tx date 2022-08-10 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
375,000 | |
| Filed 2021-09-13 15:58 Tx date 2021-09-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,100
-45,000 vol $0.18 each |
0 | |
| Filed 2021-04-19 21:34 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
250,000 | |
| Filed 2021-02-22 20:34 Tx date 2021-02-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$500.00
+10,000 vol $0.05 each |
45,000 | |
| Filed 2021-02-22 20:32 Tx date 2021-02-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-500.00
-10,000 vol $0.05 each |
175,000 | |
| Filed 2021-02-22 20:25 Tx date 2021-02-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,100
+35,000 vol $0.06 each |
35,000 | |
| Filed 2021-02-22 20:22 Tx date 2021-02-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,100
-35,000 vol $0.06 each |
185,000 | |
| Filed 2019-10-31 21:38 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
220,000 | |
| Filed 2019-06-13 11:01 Tx date 2019-04-01 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,100
+35,000 vol $0.06 each |
210,000 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,750
+25,000 vol $0.35 each |
175,000 | |
| Filed 2017-07-24 Tx date 2017-07-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
150,000 | |
| Filed 2017-05-23 Tx date 2017-04-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-23 Tx date 2017-04-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-23 Tx date 2017-04-20 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|